Nicotinell (Nicotine Polacrilex)

Nicotine Polacrilex, the active ingredient in Nicotinell, is a nicotine replacement therapy presented as a buccal formulation for buccal use. It is intended to aid adult smokers in quitting by reducing nicotine withdrawal symptoms and cravings.\n\nGNH India supplies Nicotinell as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotinell is a nicotine replacement therapy that addresses nicotine dependence and supports smoking cessation.\n\n- Smoking cessation: assists adult smokers in quitting by reducing withdrawal symptoms and cravings.\n- Tobacco dependence: provides controlled nicotine delivery to lessen dependence on cigarettes.\n- Relapse prevention: helps maintain abstinence by managing occasional urges to smoke.

Nicotinell may cause a range of adverse reactions, most of which are mild and transient.\n\nCommon Side Effects:\n- Mouth irritation or soreness\n- Throat irritation\n- Nausea\n- Headache\n- Dizziness\n- Hiccups\n\nSerious or Rare Side Effects:\n- Allergic reactions such as rash, swelling, or anaphylaxis\n- Oral ulceration or lesions\n- Increased blood pressure or hypertension\n- Chest pain or cardiac arrhythmia\n- Severe skin reactions\n- Unexplained fainting or loss of consciousness

Before using Nicotinell, consider the following safety measures.\n\n- Assess nicotine dependence: evaluate smoking history and level of dependence prior to initiation.\n- Cardiovascular risk: avoid use in patients with recent myocardial infarction or uncontrolled hypertension unless approved by a physician.\n- Concomitant nicotine products: do not use with other nicotine‑containing therapies to prevent overdose.\n- Monitor for allergic reactions: discontinue and seek medical help if severe rash or swelling occurs.\n- Store at room temperature: keep in the original pack, protect from moisture and direct heat, and keep out of reach of children.

Nicotinell can interact with other medicines; awareness of potential interactions helps ensure safe use.\n\nMajor Interactions (Avoid):\n- Monoamine oxidase inhibitors (MAOIs): may increase cardiovascular strain.\n- Beta‑blockers: nicotine‑induced tachycardia may be masked.\n- CYP2A6 inhibitors: can raise systemic nicotine levels.\n\nModerate Interactions (Monitor Closely):\n- Antidepressants (SSRIs): may enhance nausea.\n- Antihypertensive agents: nicotine may reduce blood‑pressure‑lowering effects.\n- Alcohol: combined use may increase sedation or dizziness.